| 臺大學術典藏 |
2021-09-04T06:11:00Z |
An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia
|
Hsu C.S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:58Z |
Sarcopenia and chronic liver diseases
|
Hsu C.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:31Z |
Hepatitis C virus genotypes 1–3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes
|
Hsu C.-S.; Liu W.-L.; Li Q.; Lowey B.; Hertz L.; Chao Y.-C.; Liang T.J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-08-03T01:43:27Z |
Integrated Surface Modification to Enhance the Luminescence Properties of K2TiF6:Mn4+ Phosphor and Its Application in White-Light-Emitting Diodes
|
Fang M.-H;Hsu C.-S;Su C;Liu W;Wang Y.-H;Liu R.-S.; Fang M.-H; Hsu C.-S; Su C; Liu W; Wang Y.-H; Liu R.-S.; RU-SHI LIU |
| 臺大學術典藏 |
2021-08-03T01:42:59Z |
A Universal Approach for Controllable Synthesis of n-Specific Layered 2D Perovskite Nanoplates
|
Lin J.-T;Chen D.-G;Wu C.-H;Hsu C.-S;Chien C.-Y;Chen H.-M;Chou P.-T;Chiu C.-W.; Lin J.-T; Chen D.-G; Wu C.-H; Hsu C.-S; Chien C.-Y; Chen H.-M; Chou P.-T; Chiu C.-W.; HAO MING CHEN |
| 臺大學術典藏 |
2021-08-03T01:42:58Z |
Comprehensively Probing the Contribution of Site Activity and Population of Active Sites toward Heterogeneous Electrocatalysis
|
Chen H.-C;Chen T.-L;Lin S.-C;Hsu C.-S;Chan T.-S;Liao M.-Y;Chen H.M.; Chen H.-C; Chen T.-L; Lin S.-C; Hsu C.-S; Chan T.-S; Liao M.-Y; Chen H.M.; HAO MING CHEN |
| 臺大學術典藏 |
2021-08-03T01:42:57Z |
Electronic structure inspired a highly robust electrocatalyst for the oxygen-evolution reaction
|
Zhang P;Lu Y.-R;Hsu C.-S;Xue H.-G;Chan T.-S;Suen N.-T;Chen H.M.; Zhang P; Lu Y.-R; Hsu C.-S; Xue H.-G; Chan T.-S; Suen N.-T; Chen H.M.; HAO MING CHEN |
| 臺大學術典藏 |
2021-08-03T01:42:55Z |
In Situ Identifying the Dynamic Structure behind Activity of Atomically Dispersed Platinum Catalyst toward Hydrogen Evolution Reaction
|
Wang J;Tan H.-Y;Kuo T.-R;Lin S.-C;Hsu C.-S;Zhu Y;Chu Y.-C;Chen T.L;Lee J.-F;Chen H.M.; Wang J; Tan H.-Y; Kuo T.-R; Lin S.-C; Hsu C.-S; Zhu Y; Chu Y.-C; Chen T.L; Lee J.-F; Chen H.M.; HAO MING CHEN |
| 臺大學術典藏 |
2021-08-03T01:42:54Z |
Mechanism of Oxygen Evolution Catalyzed by Cobalt Oxyhydroxide: Cobalt Superoxide Species as a Key Intermediate and Dioxygen Release as a Rate-Determining Step
|
Moysiadou A;Lee S;Hsu C.-S;Chen H.M;Hu X.; Moysiadou A; Lee S; Hsu C.-S; Chen H.M; Hu X.; HAO MING CHEN |
| 臺大學術典藏 |
2021-08-03T01:42:53Z |
Product-Specific Active Site Motifs of Cu for Electrochemical CO2 Reduction
|
Zhu C;Zhang Z;Zhong L;Hsu C.-S;Xu X;Li Y;Zhao S;Chen S;Yu J;Chen S;Wu M;Gao P;Li S;Chen H.M;Liu K;Zhang L.; Zhu C; HAO MING CHEN et al. |
| 臺大學術典藏 |
2021-08-03T01:42:53Z |
Operando time-resolved X-ray absorption spectroscopy reveals the chemical nature enabling highly selective CO2 reduction
|
Lin S.-C;Chang C.-C;Chiu S.-Y;Pai H.-T;Liao T.-Y;Hsu C.-S;Chiang W.-H;Tsai M.-K;Chen H.M.; Lin S.-C; Chang C.-C; Chiu S.-Y; Pai H.-T; Liao T.-Y; Hsu C.-S; Chiang W.-H; Tsai M.-K; Chen H.M.; HAO MING CHEN |
| 臺大學術典藏 |
2021-08-03T01:42:52Z |
The individual role of active sites in bimetallic oxygen evolution reaction catalysts
|
Wang G.-B;Hsu C.-S;Chen H.M.; Wang G.-B; Hsu C.-S; Chen H.M.; HAO MING CHEN |
| 臺大學術典藏 |
2021-08-03T01:42:50Z |
A Universal Approach for Controllable Synthesis of n-Specific Layered 2D Perovskite Nanoplates
|
Lin J.-T;Chen D.-G;Wu C.-H;Hsu C.-S;Chien C.-Y;Chen H.-M;Chou P.-T;Chiu C.-W.; Lin J.-T; Chen D.-G; Wu C.-H; Hsu C.-S; Chien C.-Y; Chen H.-M; Chou P.-T; Chiu C.-W.; CHING-WEN CHIU |
| 臺大學術典藏 |
2021-07-03T03:35:08Z |
Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan
|
Hsu C.-S.; Liu C.-J.; Lai M.-Y.; PEI-JER CHEN; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:35:03Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu C.-S.; Liu C.-J.; Liu C.-H.; Chen C.-L.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:35:00Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu C.-S.; Liu C.-J.; Liu C.-H.; Wang C.-C.; Chen C.-L.; Lai M.-Y.; PEI-JER CHEN; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:58Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu C.-H.; Liu C.-J.; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:55Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; Liu C.-J.; Wang C.-C.; Chen C.-L.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:52Z |
Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy
|
Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:49Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:46Z |
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
|
Su T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; PEI-JER CHEN; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:46Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:38Z |
Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan
|
Mah Y.-H.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:38Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:36Z |
HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection
|
Hsu S.-J.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:35Z |
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy
|
Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; Liu C.-J.; Lai M.-Y.; PEI-JER CHEN; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:31Z |
Impact of hepatitis B virus infection on metabolic profiles and modifying factors
|
Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:24Z |
IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients
|
Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:16Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:19Z |
Ropeginterferon alfa-2b every 2?weeks as a novel pegylated interferon for patients with chronic hepatitis B
|
Huang Y.-W.; Hsu C.-W.; Lu S.-N.; Yu M.-L.; Su C.-W.; Su W.-W.; Chien R.-N.; Hsu C.-S.; Hsu S.-J.; Lai H.-C.; Qin A.; Tseng K.-C.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-05-24T07:20:54Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu C.-S.; Liu C.-J.; CHEN-HUA LIU; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:54Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu C.-S.; Liu C.-J.; CHEN-HUA LIU; Wang C.-C.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-05-24T07:20:53Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
CHEN-HUA LIU; Liu C.-J.; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:53Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; CHEN-HUA LIU; Liu C.-J.; Wang C.-C.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:52Z |
Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy
|
Hsu C.-S.; CHEN-HUA LIU; Liu C.-J.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:51Z |
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
|
Su T.-H.; Hsu C.-S.; Chen C.-L.; CHEN-HUA LIU; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:50Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; CHEN-HUA LIU; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:49Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:48Z |
HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection
|
Hsu S.-J.; Hsu C.-S.; CHEN-HUA LIU; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:48Z |
Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan
|
Mah Y.-H.; Hsu C.-S.; CHEN-HUA LIU; Liu C.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:47Z |
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy
|
Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; CHEN-HUA LIU; Niu W.-F.; Jeng J.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-05-24T07:20:45Z |
Impact of hepatitis B virus infection on metabolic profiles and modifying factors
|
Hsu C.-S.; CHEN-HUA LIU; Wang C.-C.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:42Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu C.-S.; Hsu S.-J.; Chen H.-C.; CHEN-HUA LIU; Jeng J.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:16Z |
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment
|
Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; Chen C.-H.; Hsu C.-S.; Hui Y.T.; Li M.K.K.; CHEN-HUA LIU; Kan Y.-M.; Yu M.-L.; Yuen M.-F. |
| 臺大學術典藏 |
2021-05-06T01:51:59Z |
Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan
|
Wang H.-C.; Huang J.-C.; Lin Y.-H.; Chen Y.-H.; Hsieh M.-I.; Choi P.-C.; Lo H.-J.; Liu W.-L.; Hsu C.-S.; Shih H.-I.; Wu C.-J.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-03-09T01:47:47Z |
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
|
TUNG-HUNG SU; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:43Z |
Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir
|
Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; TUNG-HUNG SU; Tseng T.-C.; Hsu C.-S.; Lin H.H.; Kao J.-H. |
| 臺大學術典藏 |
2021-02-05T04:44:25Z |
Threshold effects of PM2.5 exposure on particle-related mortality in China
|
Tran, B.-L.;Chang, C.-C.;Hsu, C.-S.;Chen, C.-C.;Tseng, W.-C.;Hsu, S.-H.; Tran, B.-L.; Chang, C.-C.; Hsu, C.-S.; Chen, C.-C.; Tseng, W.-C.; Hsu, S.-H.; SHIH-HSUN HSU |
| 臺大學術典藏 |
2021-01-27T07:49:31Z |
Light-Induced Activation of Adaptive Junction for Efficient Solar-Driven Oxygen Evolution: In Situ Unraveling the Interfacial Metal–Silicon Junction
|
Tung, C.-W.;Kuo, T.-R.;Hsu, C.-S.;Chuang, Y.;Chen, H.-C.;Chang, C.-K.;Chien, C.-Y.;Lu, Y.-J.;Chan, T.-S.;Lee, J.-F.;Li, J.-Y.;Chen, H.M.; Tung, C.-W.; Kuo, T.-R.; Hsu, C.-S.; Chuang, Y.; Chen, H.-C.; Chang, C.-K.; Chien, C.-Y.; Lu, Y.-J.; Chan, T.-S.; Lee, J.-F.; Li, J.-Y.; Chen, H.M.; HAO MING CHEN |
| 臺大學術典藏 |
2021-01-27T07:49:30Z |
A Cobalt-Iron Double-Atom Catalyst for the Oxygen Evolution Reaction
|
Bai, L.;Hsu, C.-S.;Alexander, D.T.L.;Chen, H.M.;Hu, X.; Bai, L.; Hsu, C.-S.; Alexander, D.T.L.; Chen, H.M.; Hu, X.; HAO MING CHEN |
